Oncogenic mutations in PIK3CA lead to deregulation of the phosphatidylinositol 3-kinase-Akt signalling pathway, including tumour development, cell survival and cellular transformation, and are reportedly the most common genetic alterations in CC12,15. The gene discussed is PIK3CA; the disease is neoplasm.